Verastem, Inc. (VSTM)
5.39
-0.14
(-2.53%)
USD |
NASDAQ |
Mar 23, 16:00
5.36
-0.03
(-0.56%)
Pre-Market: 09:23
Verastem Shareholders Equity (Quarterly) : 57.20M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Altimmune, Inc. | 224.89M |
| ADMA Biologics, Inc. | 477.32M |
| Ocugen, Inc. | -12.17M |
| Zevra Therapeutics, Inc. | 154.66M |
| Immuneering Corp. | 218.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 246.44M |
| Total Liabilities (Quarterly) | 189.24M |
| Debt to Equity Ratio | 1.524 |
| Current Ratio | 3.092 |
| Net Debt Paydown Yield | -1.52% |